[1]吕慧清,张中民,吕仲虹.18F-氟代脱氧葡萄糖PET在恶性肿瘤适形放射治疗中的价值[J].国际放射医学核医学杂志,2006,30(6):335-337.
 LÜ,Hui-qing,ZHANG Zhong-min,et al.The value of 18F-FDG PET in three-dimensional conformal radiotherapy of cancer[J].International Journal of Radiation Medicine and Nuclear Medicine,2006,30(6):335-337.
点击复制

18F-氟代脱氧葡萄糖PET在恶性肿瘤适形放射治疗中的价值(/HTML)
分享到:

《国际放射医学核医学杂志》[ISSN:1673-4114/CN:12-1381/R]

卷:
30
期数:
2006年第6期
页码:
335-337
栏目:
临床核医学
出版日期:
1900-01-01

文章信息/Info

Title:
The value of 18F-FDG PET in three-dimensional conformal radiotherapy of cancer
作者:
吕慧清1 张中民1 吕仲虹2
1. 276003 山东临沂, 山东省临沂市人民医院放疗中心;
2. 300052 天津, 天津医科大学总医院放疗科
Author(s):
LÜ Hui-qing1 ZHANG Zhong-min1 LÜ Zhong-hong2
1. Department of radiotherapy, Linyi People’s Hospital, Shandong Linyi 276003, China;
2. Department of radiotherapy, General Hospital of Tianjin Medical University, Tianjin 350002, China
关键词:
氟脱氧葡萄糖F18体层摄影术发射型计算机放射疗法适形肿瘤
Keywords:
Fluorodeoxyglucose F18Tomography emission-computedRadiotherapy conformalNeoplasms
分类号:
R817.4
摘要:
三维适形放射治疗是以影像学为指导的放射治疗技术,肿瘤的准确分期和准确勾画肿瘤靶体积是三维适形放射治疗中的重要环节。18F-氟代脱氧葡萄糖(18F-FDG)PET能够提高肿瘤的诊断准确率、肿瘤分期的准确性,对恶性肿瘤治疗方案做出正确选择,对准确详尽地描绘肿瘤范围和肿瘤组织与周围正常组织的关系有极大帮助。
Abstract:
Three-dimensional conformal radiotherapy (3D-CRT) is based on an extensive use of modem medical imaging techniques. Delineation of the gross tumor volume and organs at risk constitutes one of the most important phases of conformal radiotherapy procedures. 18F-fluorodeoxyghcose (18F-FDG) PET possesses greater sensitivity and accuracy in detecting diseased lymph nodes, is an important staging examination for patients considered for radiation treatment with curative intent, 18F-FDG PET has an important role in delineation of gross tumor volume for patients treated with three-dimensional conformal radiotherapy.

参考文献/References:

1 Michalski J, Purdy JA, Gaspar L, et al. Image-guided radiation therapy committee. Int J Radiat Oncol Biol Phys, 2001, 51(3 suppl 2):60-65.
2 Salminen E, Mac Manus M. Impact of FDG-labelled positron emission tomography imaging on the management of non-small-cell lung cancer. Ann Med, 2001, 33(6):404-409.
3 Mah K, Caldwell CB, Ung YC, et al. The impact of 18F-FDG PET on target and critical organs in CT-based treatment planning of patients with poorly defined non-small-cell lung carcinoma:a prospec fivestudy. Int J Radiat Oncol Biol Phys, 2002, 52(2):339-350.
4 Giraud P, Grahek D, Montravers F, et al. CT and 18F-deoxyglucose (FDG) image fusion for optimization of conformal radiotherapy of lung cancers. Int J Radiat Oncol Biol Phys, 2001, 49(5):1249-1257.
5 Vanuytsel LJ, Vansteenkiste JF, Stroobants SG, et al. The impact of 18F-fluoro-2-deoxy-D-glucose positron emission tomography (FDG-PET) lymph node staging on the radiation treatment volumes in patients with non-small-cell lung cancer. Radiother Oncol,2000, 55(3):317-324.
6 Deslauriers J, Gregoire J. Clinical and surgical staging of non-small cell lung cancer. Chest, 2000, 117(4 Suppl 1):96S-103S.
7 Gupta NC, Graeber GM, Bishop HA. Comparative efficacy of positron emission tomography with fluorodeoxyglucose in evaluation of small (<1 cm), intermediate (1 to 3 cm) and large (>3 cm) lymph node lesions. Chest, 2000, 117(3):773-778.
8 Schwartz DL, Ford E, Rajendran J, et al. FDG-PET/CT imageing for preradiotherapy staging of head-and-neck squamous cell carcinoma. Int J Radiat Oncol Biol Phys, 2005, 61(1):129-136.
9 Hicks RJ, Kalff V, MacManus MP, et al. 18F-FDG PET provides high-Impact and powerful prognostic stratification in staging newly diagnosed non-small cell lung cancer. J Nucl Med, 2001, 42(11):1596-1604.
10 MacManus MP, Hicks RJ, Matthews JP, et al. High rate of detection of unsuspected metastases by PET in apparent stage Ⅲ NSCLC:implications for radical radiation therapy. Int J Badiat Oncol Biol Phys, 2001, 50(2):287-293.
11 Kalff V, Hicks RJ, MacManus MP, et al. Clinical impact of 18F fluorodeoxyglucose poositron emission tomography in patients with non-small-cell lung cancer. A prospective study. J Clin Oncol,2001, 19(1):111-118.
12 Dizendorf EV, Baumert BG, Von Schulthess GK, et al. Impact of whole-body 18F-FDG PET on staging and managing patients for radiation therapy. J Nucl Med, 2003, 44(1):24-29.
13 Caldwell CB, Mah K, Ung YC, et al. Observer variation in contouring gross tumor volume in patients with poorly defined non-small-cell lung tumors on CT:the impact of 18FDG-hybrid PET fusion. Int J Radlat Oncol Biol Phys, 2001, 51(4):923-931.
14 Vrieze O, Haustermans K, de Wever W, et al. Is there a role of FDG-PET in radiotherapy planning in esophageal carcinoma?.Radiother Oncol, 2004, 73(3):269-275.

相似文献/References:

[1]周玉祥,蓝博文,黄春榆,等.64排螺旋CT冠状动脉血管成像诊断冠状动脉-肺动脉瘘的应用价值[J].国际放射医学核医学杂志,2016,40(1):26.[doi:10.3760/cma.j.issn.1673-4114.2016.01.006]
 Zhou Yuxiang,Lan Bowen,Huang Chunyu,et al.Clinical value of coronary artery-pulmonary artery fistula revealed by 64-slice spiral CT coronary angiography[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(6):26.[doi:10.3760/cma.j.issn.1673-4114.2016.01.006]
[2]陈超坤,刘亮,傅飞先,等.囊性胸腺瘤和囊性畸胎瘤的影像学特征及鉴别诊断[J].国际放射医学核医学杂志,2016,40(1):31.[doi:10.3760/cma.j.issn.1673-4114.2016.01.007]
 Chen Chaokun,Liu Liang,Fu Feixian,et al.Imaging features and differential diagnosis of cystic thymoma and cystic teratoma[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(6):31.[doi:10.3760/cma.j.issn.1673-4114.2016.01.007]
[3]岳进,苏丽萍.全身MRI与PET/CT在淋巴瘤骨髓浸润诊断及预后中的作用[J].国际放射医学核医学杂志,2016,40(1):50.[doi:10.3760/cma.j.issn.1673-4114.2016.01.010]
 Yue Jin,Su Lipin.Function of whole-body MRI and PET/CT in the diagnosis and prognosis of lymphoma with bone marrow infiltration[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(6):50.[doi:10.3760/cma.j.issn.1673-4114.2016.01.010]
[4]张莹莹,王振光,孔艳.PET/CT显像在肺间质纤维化中的应用进展[J].国际放射医学核医学杂志,2016,40(1):55.[doi:10.3760/cma.j.issn.1673-4114.2016.01.011]
 Zhang Yingying,Wang Zhenguang,Kong Yan.Application advancement on PET/CT in pulmonary interstitial fibrosis[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(6):55.[doi:10.3760/cma.j.issn.1673-4114.2016.01.011]
[5]麦卫平,张永林.能谱CT成像在肺癌诊断中的应用研究进展[J].国际放射医学核医学杂志,2016,40(1):77.[doi:10.3760/cma.j.issn.1673-4114.2016.01.015]
 Mai Weiping,Zhang Yonglin.Research progress of spectral imaging in the diagnosis of lung cancer[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(6):77.[doi:10.3760/cma.j.issn.1673-4114.2016.01.015]
[6]周翠屏,廖俊杰,何国华,等.原发性肠系膜巨大淋巴结增生症的MSCT表现与病理对照分析[J].国际放射医学核医学杂志,2016,40(3):175.[doi:10.3760/cma.j.issn.1673-4114.2016.03.003]
 Zhou Cuiping,Liao Junjie,He Guohua,et al.Primary mesenteric Castleman disease:MSCT findings with histopathologic correlation[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(6):175.[doi:10.3760/cma.j.issn.1673-4114.2016.03.003]
[7]张巧娜,刘汉东.上颌窦上皮-肌上皮癌的CT表现一例[J].国际放射医学核医学杂志,2016,40(3):237.[doi:10.3760/cma.j.issn.1673-4114.2016.03.015]
[8]刘淑蓉,孙凯.低辐射剂量冠状动脉成像的研究进展[J].国际放射医学核医学杂志,2016,40(4):293.[doi:10.3760/cma.j.issn.1673-4114.2016.04.011]
 Liu Shurong,Sun Kai.The advances of low radiation dose coronary computed tomography angiography imaging[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(6):293.[doi:10.3760/cma.j.issn.1673-4114.2016.04.011]
[9]郑雪,孙凯.双源双能量CT心肌灌注成像的研究进展[J].国际放射医学核医学杂志,2016,40(4):301.[doi:10.3760/cma.j.issn.1673-4114.2016.04.013]
 Zheng Xue,Sun Kai.Progress of dual-energy myocardial perfusion imaging by dual-source computed tomography[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(6):301.[doi:10.3760/cma.j.issn.1673-4114.2016.04.013]
[10]张巍,杨珂.18f正电子放射性药物生产及使用中医务人员的受照剂量研究[J].国际放射医学核医学杂志,2015,39(5):420.[doi:10. 3760 / cma. j. issn. 1673-4114. 2015. 05. 016]
 zhang wei,yang ke..the research of radiation dose of 18f-fdg to pet/ct related personnel[J].International Journal of Radiation Medicine and Nuclear Medicine,2015,39(6):420.[doi:10. 3760 / cma. j. issn. 1673-4114. 2015. 05. 016]
[11]史文杰,孟召伟,谭建.基于Deauville标准探讨18F-FDG PET/CT在霍奇金淋巴瘤复发诊断中的应用价值[J].国际放射医学核医学杂志,2016,40(2):120.[doi:10.3760/cma.j.issn.1673-4114.2016.02.007]
 Shi Wenjie,Meng Zhaowei,Tan Jian.Value of 18F-FDG PET/CT on diagnosis of Hodgkin lymphoma recurrence using Deauville criterion[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(6):120.[doi:10.3760/cma.j.issn.1673-4114.2016.02.007]
[12]尤阳,轩昂,张杰,等.淋巴瘤患者大脑静息葡萄糖代谢改变[J].国际放射医学核医学杂志,2016,40(4):255.[doi:10.3760/cma.j.issn.1673-4114.2016.04.003]
 You Yang,Xuan Ang,Zhang Jie,et al.Changes in resting-state brain glucose metabolism in patients with lymphoma[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(6):255.[doi:10.3760/cma.j.issn.1673-4114.2016.04.003]
[13]王朋,崔邦平,代文莉,等.18F-FDG PET/CT在前列腺癌中的应用进展[J].国际放射医学核医学杂志,2016,40(4):277.[doi:10.3760/cma.j.issn.1673-4114.2016.04.008]
 Wang Peng,Cui Bangping,Dai Wenli,et al.Progress in the application of 18F-FDG PET/CT in prostate cancer[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(6):277.[doi:10.3760/cma.j.issn.1673-4114.2016.04.008]
[14]李菲,黄俊星,张俊.18F-FDG PET/CT在食管癌中的临床应用[J].国际放射医学核医学杂志,2016,40(4):282.[doi:10.3760/cma.j.issn.1673-4114.2016.04.009]
 Li Fei,Huang Junxing,Zhang Jun.The clinical application of 18F-FDG PET/CT in esophageal cancer[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(6):282.[doi:10.3760/cma.j.issn.1673-4114.2016.04.009]
[15]曹登敏,林美福,陈文新,等.继发性骨淋巴瘤的18F-FDG PET/CT影像学表现[J].国际放射医学核医学杂志,2016,40(6):403.[doi:10.3760/cma.j.issn.1673-4114.2016.06.001]
 Cao Dengmin,Lin Meifu,Chen Wenxin,et al.Analysis on 18F-FDG PET/CT imaging characteristics in secondary bone lymphoma[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(6):403.[doi:10.3760/cma.j.issn.1673-4114.2016.06.001]
[16]李生栩,唐明灯,林端瑜,等.18F-FDG PET/CT在胸段食管鳞癌淋巴结转移中的诊断价值[J].国际放射医学核医学杂志,2016,40(6):408.[doi:10.3760/cma.j.issn.1673-4114.2016.06.002]
 Li Shengxu,Tang Mingdeng,Lin Duanyu,et al.Value of 18F-FDG PET/CT in detecting metastatic lymph nodes of thoracic esophageal squamous cell carcinoma[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(6):408.[doi:10.3760/cma.j.issn.1673-4114.2016.06.002]
[17]张莹莹,王振光,武凤玉,等.特发性肺间质纤维化HRCT病变区与非病变区18F-FDG PET/CT表现分析[J].国际放射医学核医学杂志,2016,40(6):414.[doi:10.3760/cma.j.issn.1673-4114.2016.06.003]
 Zhang Yingying,Wang Zhenguang,Wu Fengyu,et al.18F-FDG PET/CT imaging analysis of regions with abnormal and normal pulmonary parenchyma on high resolution CT in idiopathic pulmonary fibrosis patients[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(6):414.[doi:10.3760/cma.j.issn.1673-4114.2016.06.003]
[18]张毓艺,姚稚明.18F-FDG PET/CT对非小细胞肺癌淋巴结分期诊断价值的研究进展[J].国际放射医学核医学杂志,2016,40(6):447.[doi:10.3760/cma.j.issn.1673-4114.2016.06.009]
 Zhang Yuyi,Yao Zhiming.The progress of 18F-FDG PET/CT in the diagnosis of N-staging of non-small cell lung cancer[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(6):447.[doi:10.3760/cma.j.issn.1673-4114.2016.06.009]
[19]郝新忠,武志芳,武萍,等.SAPHO综合征18F-FDG PET/CT显像和临床分析[J].国际放射医学核医学杂志,2015,39(6):447.[doi:10.3760/cma.j.issn.1673-4114.2015.06.003]
 Hao Xinzhong,Wu Zhifang,Wu Ping,et al.18F-FDG PET/CT imaging and clinical features of SAPHO syndrome[J].International Journal of Radiation Medicine and Nuclear Medicine,2015,39(6):447.[doi:10.3760/cma.j.issn.1673-4114.2015.06.003]
[20]周文兰,吴湖炳,韩彦江,等.18F-FDG PET/CT对骨骼孤立性高代谢病灶的初步诊断价值[J].国际放射医学核医学杂志,2015,39(1):14.[doi:10.3760/cma.j.issn.1673-4114.2015.01.005]
 Zhou Wenlan,Wu Hubing,Han Yanjiang,et al.Preliminary study of 18F-FDG PET/CT in the diagnosis of solitary hypermetabolic lesion of bone[J].International Journal of Radiation Medicine and Nuclear Medicine,2015,39(6):14.[doi:10.3760/cma.j.issn.1673-4114.2015.01.005]

备注/Memo

备注/Memo:
收稿日期:2005-12-12。
通讯作者:张中民,E-mail:zhangzhongmin@csco.org.cn
更新日期/Last Update: 1900-01-01